These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 8905411)
1. Identification of a second site in HIV-1 gp41 mediating binding to cells. Chen YH; Dierich MP Immunol Lett; 1996 Sep; 52(2-3):153-6. PubMed ID: 8905411 [TBL] [Abstract][Full Text] [Related]
2. Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions. Neurath AR; Strick N; Lin K; Jiang S AIDS Res Hum Retroviruses; 1995 Jun; 11(6):687-96. PubMed ID: 7576928 [TBL] [Abstract][Full Text] [Related]
3. A predefined epitope-specific monoclonal antibody recognizes ELDEWA-epitope just presenting on gp41 of HIV-1 O clade. Huang J; Dong X; Liu Z; Qin L; Chen YH Immunol Lett; 2002 Dec; 84(3):205-9. PubMed ID: 12413738 [TBL] [Abstract][Full Text] [Related]
4. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems. Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693 [TBL] [Abstract][Full Text] [Related]
5. ELNKWA-epitope specific antibodies induced by epitope-vaccine recognize ELDKWA- and other two neutralizing-resistant mutated epitopes on HIV-1 gp41. Dong XN; Xiao Y; Chen YH Immunol Lett; 2001 Jan; 75(2):149-52. PubMed ID: 11137140 [TBL] [Abstract][Full Text] [Related]
6. The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes. Alam SM; McAdams M; Boren D; Rak M; Scearce RM; Gao F; Camacho ZT; Gewirth D; Kelsoe G; Chen P; Haynes BF J Immunol; 2007 Apr; 178(7):4424-35. PubMed ID: 17372000 [TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1-neutralizing monoclonal antibody 2F5 is multispecific for sequences flanking the DKW core epitope. Menendez A; Chow KC; Pan OC; Scott JK J Mol Biol; 2004 Apr; 338(2):311-27. PubMed ID: 15066434 [TBL] [Abstract][Full Text] [Related]
8. Structure-affinity relationships in the gp41 ELDKWA epitope for the HIV-1 neutralizing monoclonal antibody 2F5: effects of side-chain and backbone modifications and conformational constraints. Tian Y; Ramesh CV; Ma X; Naqvi S; Patel T; Cenizal T; Tiscione M; Diaz K; Crea T; Arnold E; Arnold GF; Taylor JW J Pept Res; 2002 Jun; 59(6):264-76. PubMed ID: 12010517 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal Antibody 2C6 Targets a Cross-Clade Conformational Epitope in gp41 with Highly Active Antibody-Dependent Cell Cytotoxicity. Sojar H; Baron S; Sullivan JT; Garrett M; van Haaren MM; Hoffman J; Overbaugh J; Doranz BJ; Hicar MD J Virol; 2019 Sep; 93(17):. PubMed ID: 31217246 [TBL] [Abstract][Full Text] [Related]
10. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization. Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698 [TBL] [Abstract][Full Text] [Related]
11. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. Purtscher M; Trkola A; Gruber G; Buchacher A; Predl R; Steindl F; Tauer C; Berger R; Barrett N; Jungbauer A AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1651-8. PubMed ID: 7888224 [TBL] [Abstract][Full Text] [Related]
12. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site. Julien JP; Bryson S; Nieva JL; Pai EF J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005 [TBL] [Abstract][Full Text] [Related]
13. Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody. Conley AJ; Kessler JA; Boots LJ; Tung JS; Arnold BA; Keller PM; Shaw AR; Emini EA Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3348-52. PubMed ID: 7512731 [TBL] [Abstract][Full Text] [Related]
14. Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution. Shen X; Dennison SM; Liu P; Gao F; Jaeger F; Montefiori DC; Verkoczy L; Haynes BF; Alam SM; Tomaras GD Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5972-7. PubMed ID: 20231447 [TBL] [Abstract][Full Text] [Related]
15. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. Stiegler G; Kunert R; Purtscher M; Wolbank S; Voglauer R; Steindl F; Katinger H AIDS Res Hum Retroviruses; 2001 Dec; 17(18):1757-65. PubMed ID: 11788027 [TBL] [Abstract][Full Text] [Related]
16. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1. Zwick MB; Jensen R; Church S; Wang M; Stiegler G; Kunert R; Katinger H; Burton DR J Virol; 2005 Jan; 79(2):1252-61. PubMed ID: 15613352 [TBL] [Abstract][Full Text] [Related]
17. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10. Nelson JD; Brunel FM; Jensen R; Crooks ET; Cardoso RM; Wang M; Hessell A; Wilson IA; Binley JM; Dawson PE; Burton DR; Zwick MB J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272 [TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6. Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506 [TBL] [Abstract][Full Text] [Related]
20. Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. Ofek G; Tang M; Sambor A; Katinger H; Mascola JR; Wyatt R; Kwong PD J Virol; 2004 Oct; 78(19):10724-37. PubMed ID: 15367639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]